These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22918538)

  • 21. Native State Mass Spectrometry, Surface Plasmon Resonance, and X-ray Crystallography Correlate Strongly as a Fragment Screening Combination.
    Woods LA; Dolezal O; Ren B; Ryan JH; Peat TS; Poulsen SA
    J Med Chem; 2016 Mar; 59(5):2192-204. PubMed ID: 26882437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular-Simulation-Driven Fragment Screening for the Discovery of New CXCL12 Inhibitors.
    Martinez-Rosell G; Harvey MJ; De Fabritiis G
    J Chem Inf Model; 2018 Mar; 58(3):683-691. PubMed ID: 29481075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMR quality control of fragment libraries for screening.
    Sreeramulu S; Richter C; Kuehn T; Azzaoui K; Blommers MJJ; Del Conte R; Fragai M; Trieloff N; Schmieder P; Nazaré M; Specker E; Ivanov V; Oschkinat H; Banci L; Schwalbe H
    J Biomol NMR; 2020 Nov; 74(10-11):555-563. PubMed ID: 32533387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Native Mass Spectrometry in Fragment-Based Drug Discovery.
    Pedro L; Quinn RJ
    Molecules; 2016 Jul; 21(8):. PubMed ID: 27483215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant Kinase Production and Fragment Screening by NMR Spectroscopy.
    Han B; Ahn HC
    Methods Mol Biol; 2016; 1360():35-46. PubMed ID: 26501900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput screening for enzyme inhibitors using frontal affinity chromatography with liquid chromatography and mass spectrometry.
    Ng ES; Yang F; Kameyama A; Palcic MM; Hindsgaul O; Schriemer DC
    Anal Chem; 2005 Oct; 77(19):6125-33. PubMed ID: 16194069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assaying small-molecule-receptor interactions by continuous flow competitive displacement chromatography/mass spectrometry.
    Sharma J; Besanger TR; Brennan JD
    Anal Chem; 2008 May; 80(9):3213-20. PubMed ID: 18351752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SPR-based fragment screening: advantages and applications.
    Neumann T; Junker HD; Schmidt K; Sekul R
    Curr Top Med Chem; 2007; 7(16):1630-42. PubMed ID: 17979772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical modulation of the proteolytic profile of Transforming Growth Factor Beta induced protein (TGFBIp) offers a new avenue for treatment of
    Venkatraman A; Duong-Thi MD; Pervushin K; Ohlson S; Mehta JS
    J Adv Res; 2020 Jul; 24():529-543. PubMed ID: 32637173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Label-free primary screening and affinity ranking of fragment libraries using parallel analysis of protein panels.
    Hämäläinen MD; Zhukov A; Ivarsson M; Fex T; Gottfries J; Karlsson R; Björsne M
    J Biomol Screen; 2008 Mar; 13(3):202-9. PubMed ID: 18270366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug-plasma protein interactions.
    Vuignier K; Guillarme D; Veuthey JL; Carrupt PA; Schappler J
    J Pharm Biomed Anal; 2013 Feb; 74():205-12. PubMed ID: 23245252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMR characterization of weak interactions between RhoGDI2 and fragment screening hits.
    Liu J; Gao J; Li F; Ma R; Wei Q; Wang A; Wu J; Ruan K
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3061-3070. PubMed ID: 27721047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct analysis - no sample preparation - of bioavailable cortisol in human plasma by weak affinity chromatography (WAC).
    Ohlson S; Kaur J; Raida M; Niss U; Bengala T; Drum CL; Boehm B; Torres AR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():438-444. PubMed ID: 28820982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
    Hoffer L; Renaud JP; Horvath D
    J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipodisks integrated with weak affinity chromatography enable fragment screening of integral membrane proteins.
    Duong-Thi MD; Bergström M; Edwards K; Eriksson J; Ohlson S; Ying JT; Torres J; Hernández VA
    Analyst; 2016 Feb; 141(3):981-8. PubMed ID: 26673836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of Fragment-Based Drug Discovery to Versatile Targets.
    Li Q
    Front Mol Biosci; 2020; 7():180. PubMed ID: 32850968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frontal affinity chromatography with MS detection of the ligand binding domain of PPARγ receptor: ligand affinity screening and stereoselective ligand-macromolecule interaction.
    Calleri E; Fracchiolla G; Montanari R; Pochetti G; Lavecchia A; Loiodice F; Laghezza A; Piemontese L; Massolini G; Temporini C
    J Chromatogr A; 2012 Apr; 1232():84-92. PubMed ID: 22056242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How Size Matters: Diversity for Fragment Library Design.
    Shi Y; von Itzstein M
    Molecules; 2019 Aug; 24(15):. PubMed ID: 31387220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of B. anthracis N(5)-carboxyaminoimidazole ribonucleotide mutase (PurE) active site binding compounds via fragment library screening.
    Lei H; Jones C; Zhu T; Patel K; Wolf NM; Fung LW; Lee H; Johnson ME
    Bioorg Med Chem; 2016 Feb; 24(4):596-605. PubMed ID: 26740153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
    Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
    J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.